Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Pruvost

Showing results (41-50 of 64) with videos related to

Pageof 7
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trialDominique Salmon-Céron, Régis Lassalle, Alain Pruvost, et al.
Molecular Pharmaceutics|March 29, 2011
In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discoveryOlivier Lacombe, Orianne Videau, Delphine Chevillon, et al.
Plos One|July 11, 2013
Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected PatientsPere Domingo, Maria Gracia Mateo, Alain Pruvost, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Association of thymidylate synthase gene polymorphisms with stavudine triphosphate intracellular levels and lipodystrophyPere Domingo, M Carmen Cabeza, Alain Pruvost, et al.
Scientific Reports|November 7, 2019
Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier ModelGwenaëlle Le Roux, Rafika Jarray, Anne-Cécile Guyot, et al.
AIDS (London, England)|December 13, 2016
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'IvoireArne Kroidl, Frederic Ello, Jimson Mgaya, et al.
Chemical Science|October 28, 2024
A cancer immunoprofiling strategy using mass spectrometry coupled with bioorthogonal cleavageMaxime Ribéraud, Estelle Porret, Alain Pruvost, et al.
The Journal of Clinical Investigation|March 20, 2018
The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaquesMireille Laforge, Ricardo Silvestre, Vasco Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2)Déborah Hirt, Didier K Ekouévi, Alain Pruvost, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Activity of Bisnaphthalimidopropyl Derivatives against Trypanosoma bruceiNuno A G Graça, Luis Gaspar, David M Costa, et al.
Pageof 7

Showing results (41-50 of 64) with videos related to

Sort By:
Pageof 7
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 15, 2003
Interferon-ribavirin in association with stavudine has no impact on plasma human immunodeficiency virus (HIV) type 1 level in patients coinfected with HIV and hepatitis C virus: a CORIST-ANRS HC1 trialDominique Salmon-Céron, Régis Lassalle, Alain Pruvost, et al.
Molecular Pharmaceutics|March 29, 2011
In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discoveryOlivier Lacombe, Orianne Videau, Delphine Chevillon, et al.
Plos One|July 11, 2013
Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected PatientsPere Domingo, Maria Gracia Mateo, Alain Pruvost, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2011
Association of thymidylate synthase gene polymorphisms with stavudine triphosphate intracellular levels and lipodystrophyPere Domingo, M Carmen Cabeza, Alain Pruvost, et al.
Scientific Reports|November 7, 2019
Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier ModelGwenaëlle Le Roux, Rafika Jarray, Anne-Cécile Guyot, et al.
AIDS (London, England)|December 13, 2016
Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Côte d'IvoireArne Kroidl, Frederic Ello, Jimson Mgaya, et al.
Chemical Science|October 28, 2024
A cancer immunoprofiling strategy using mass spectrometry coupled with bioorthogonal cleavageMaxime Ribéraud, Estelle Porret, Alain Pruvost, et al.
The Journal of Clinical Investigation|March 20, 2018
The anti-caspase inhibitor Q-VD-OPH prevents AIDS disease progression in SIV-infected rhesus macaquesMireille Laforge, Ricardo Silvestre, Vasco Rodrigues, et al.
Antimicrobial Agents and Chemotherapy|April 6, 2011
Plasma and intracellular tenofovir pharmacokinetics in the neonate (ANRS 12109 trial, step 2)Déborah Hirt, Didier K Ekouévi, Alain Pruvost, et al.
Antimicrobial Agents and Chemotherapy|January 21, 2016
Activity of Bisnaphthalimidopropyl Derivatives against Trypanosoma bruceiNuno A G Graça, Luis Gaspar, David M Costa, et al.
Pageof 7